H.R.5235: To ensure the timely availability of generic drugs through enhancement of drug approval and antitrust laws enforced by the Food and Drug Administration and the Federal Trade Commission regarding brand name drugs and generic drugs.

About This Bill

• See it on GovTrack
• See it on C-SPAN

• This bill was introduced in the 106th Congress
• This bill is primarily about law
• Introduced Sept. 20, 2000
• Latest Major Action Oct. 20, 2000
• See the one similar bills introduced in other congresses.

Bill Sponsor

• Henry A. Waxman (D-Calif.)